DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Denufosol is an investigational drug.
There have been 15 clinical trials for Denufosol. The most recent clinical trial was a Phase 3 trial, which was initiated on July 1st 2006.
The most common disease conditions in clinical trials are Fibrosis, Cystic Fibrosis, and Lung Diseases. The leading clinical trial sponsors are Merck Sharp & Dohme Corp., Cystic Fibrosis Foundation Therapeutics, and [disabled in preview].
Recent Clinical Trials for Denufosol
|A Safety and Tolerability Study of Denufosol in 2-4 Year Olds||Merck Sharp & Dohme Corp.||Phase 2|
|Study 08-114 Open-label Extension of Study 08-110 - A Multi-Center Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis Lung Disease (P08642)||Merck Sharp & Dohme Corp.||Phase 3|
|Study of Denufosol Tetrasodium Inhalation Solution in Patients With Cystic Fibrosis (CF) Lung Disease||Merck Sharp & Dohme Corp.||Phase 3|